Search clinical trials for: rhPTH(1-84)

Total 14187 results

Shire

Completed

Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism (PARALLAX)

Hypoparathyroidism

United States, Hungary, Canada, Denmark
Shire

Completed

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

Hypoparathyroidism

United States
John P. Bilezikian
Shire; NPS Pharma

Unknown

HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism

Hypoparathyroidism

United States
National Institute of Diabetes and Digestive and...

Unknown

ADD-ON Study to Existing Hypoparathyroidism Studies

Hypoparathyroidism

United States
Shire

Completed

A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism

Hypoparathyroidism | Chronic Hypoparathyroidism

United States
Shire

Withdrawn

A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism

Chronic Hypoparathyroidism

Japan
Shire

Terminated

Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism

Hypoparathyroidism

United States, Hungary, Denmark, Canada
Shire

Completed

A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)

Hypoparathyroidism

United States, Spain, United Kingdom, Denmark, France, Norway, Belgium, Canada, Portugal, Sweden, Italy, Netherlands, Germany
Takeda
Takeda Development Center Americas, Inc.

Completed

A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults

Healthy Volunteers

United States
John P. Bilezikian
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Bone Properties in Hypoparathyroidism: Effects of PTH

Hypoparathyroidism

United States
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Unknown

G56W1 in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

China
Ruijin Hospital
RenJi Hospital; West China Hospital; Shandong Provincial Hospital; Tianjin Medical... and other collaborators

Not yet recruiting

Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)

Peripheral T Cell Lymphoma

China
Southeast Renal Research Institute

Withdrawn

Vitamin D and Carboxy PTH Fragments in Coronary Calcification

Endstage Renal Disease | Coronary Calcification | Parathyroid Hormone

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

Osteoporosis

United States
U.S. Army Medical Research and Development Command

Not yet recruiting

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults (VEE)

Venezuelan Equine Encephalomyelitis

United States
Invitae Corporation

Recruiting

Universal Germline Testing in the Community (UNITY)

Cancer | Solid Tumor | Solid Tumor, Adult

United States
Eli Lilly and Company
TransPharma Medical

Completed

A Study for the Transdermal Application of Teriparatide

Osteoporosis

Hungary, Romania, Mexico, Argentina, Estonia
Purdue University
Mushroom Council

Completed

Mushroom Ingestion Study

Diet, Healthy

United States
National Institute of Dental and Craniofacial Research...

Terminated

Effects of PTH Replacement on Bone in Hypoparathyroidism

DiGeorge Syndrome | Hypoparathyroidism

United States
Bayer

Completed

Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)

Hypersensitivity

United States
University of California, San Francisco

Completed

PTH & Ibandronate Combination Study (PICS) (PICS)

Osteoporosis

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 (VEE C-84)

Venezuelan Equine Encephalomyelitis

United States
Glostrup University Hospital, Copenhagen
The Danish Medical Research Council

Withdrawn

Effect of PTH(1-34) Treatment on Fracture Healing in Vivo

Shoulder Fractures | Trochanteric Fractures

Denmark
424 General Military Hospital
Beth Israel Deaconess Medical Center

Completed

Circulating Myokine Levels and Bone Metabolism

Osteoporosis, Postmenopausal

Greece
Critical Outcome Technologies Inc.
M.D. Anderson Cancer Center; Northwestern Memorial Hospital

Unknown

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies (COTI2-101)

Cervical Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Lung Cancer | Endometrial Cancer | Peritoneal Cancer | HNSCC

United States
University of Bergen
Haukeland University Hospital

Unknown

Corticosteroid Rhythms in Hypoparathyroid Patients

Hyperparathyroidism | Hypoparathyroidism

Norway
Rigshospitalet, Denmark

Recruiting

Agreements Between Transcutaneous and Arterial Monitoring of Oxygen and Carbon Dioxide After Non-cardiac Surgery

Post Anesthesia Care Optimaization

Denmark
Entera Bio Ltd.

Completed

Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism

Hypoparathyroidism

Israel
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine

Virus Diseases | Parainfluenza

United States
University of Aarhus

Completed

Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life (HypoPTH)

Hypoparathyroidism

Denmark
Massachusetts General Hospital
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women

Osteoporosis | Postmenopausal Osteoporosis

United States
Ass. Prof. Jan Nyman

Terminated

Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy (PLANET)

Non Small Cell Lung Cancer | Locally Advanced Disease

Sweden
Takeda

Completed

Adherence to PTH(1-84) Treatment (FP-002-IM)

Clinical Use of PTH(1-84)

Denmark
Hvidovre University Hospital
Takeda

Unknown

Parathyroid Hormone for the Treatment of Humerus Fractures

Shoulder Fractures

Denmark
Vernalis (R&D) Ltd

Completed

Safety and Efficacy Study in Acute Ischaemic Stroke (VASST)

Stroke

United States, Canada
Hoffmann-La Roche

Completed

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

Primary Myelofibrosis | Polycythemia Vera | Post-Essential Thrombocythemia Myelofibrosis

United States, Netherlands, Italy, United Kingdom, Canada, France, Germany, Israel
Entera Bio Ltd.

Completed

A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass

Osteoporosis

Israel
Nycomed

Terminated

The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)

Back Pain

Denmark
Janssen Research & Development, LLC

Completed

A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression (SYNAPSE)

Treatment Resistant Depressive Disorder

United States, Japan, Belgium
Entera Bio Ltd.

Recruiting

Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

Hypoparathyroidism

Israel
Nycomed

Completed

Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)

Osteoporosis

Denmark
University of Chicago

Terminated

rhPTH Therapy for Low Turnover Bone Fragility

Osteopetrosis

United States
National Institute of Diabetes and Digestive and...

Completed

Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis

Osteoporosis

United States
Janssen Pharmaceutical K.K.

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression

Depression

Japan
K.Lance Gould
Gilead Sciences

Completed

Darusentan Effect on PET Uptake Heterogeneity (Darusentan)

Coronary Artery Disease | Endothelial Dysfunction

United States
Massachusetts General Hospital
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Alendronate and/or Parathyroid Hormone for Osteoporosis

Osteoporosis

United States
University of California, Davis
University of California, San Francisco

Completed

Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use

Osteoporosis

United States
Istanbul University

Recruiting

WALANT and Spinal Anesthesia Comparison of Clinical Result in Ankle Fractures

Ankle Fractures

Turkey
Joseph Baar, MD, PhD

Completed

Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients

Breast Cancer | Metastatic Breast Cancer

United States

Search clinical trials for: rhPTH(1-84)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations